As the world is recognising the World Intellectual Property Day on April 26, we consider how the current system uses Intellectual Property and licenses in the case of antibiotics. Deciphering the role of intellectual property is a critical element in constructing a workable end-to-end model for sustainable access to novel antibiotics. In this interview with Esteban Burrone, the head of policy for the Medicines Patent Pool, we examine the particular role that the Medicines Patent Pool and licensing could play in such an end-to-end model.
ReAct is an independent network dedicated to the problem of antibiotic resistance. ReAct is a global catalyst, advocating and stimulating for global engagement on antibiotic resistance through a broad range of collaborations.
The competition Innovate4AMR invites student teams from around the world to design innovative solutions for antimicrobial stewardship in resource-limited healthcare settings.
This new report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development when the drugs don’t work and a post-antibiotic era sets in. The report shows how antibiotic resistance is a global development problem by highlighting existing data and people’s experiences.
International Mother Earth Day is a day to reflect on the relation between nature and humans. Human beings’ permanence depends on the existence of other species, animals, plants and natural elements such as land, water and air. In this framework ReAct Latin America honors life in commemoration of Earth Day.
When discussing and developing interventions to curb antibiotic resistance, it is important to consider the constraints, especially in many low- and middle-income countries (LMICs). Some interventions and technologies are simply not possible to implement – this holds true regardless of the novelty of the intervention, but becomes especially apparent for new high-tech innovations. The problems exist all over the field of innovation, but in this article, we’ll focus on diagnostics for illustration.
ReAct has for many years focused much effort on driving the issue of antibiotic resistance up the global political agenda. Today global political awareness about antibiotic resistance has reached unprecedented levels. Now ReAct will align its work to respond to the next challenge: to ensure that the long-awaited response is corresponding to meet the actual needs, in particular in low- and middle-income countries. To address this new situation, ReAct will focus on four strategic areas in the coming five years, this with continued core funding from Sida.
The ReAct Toolbox is a user-friendly web-based resource that provides inspiration and guidance to take action and develop national action plans on antibiotic resistance. It is built on what has been done in the past in a variety of settings, and is aligned with ongoing and current initiatives from across the globe.
ReAct is a global network of antibiotic resistance experts with nodes in Africa, Asia Pacific, Europe, Latin America and North America.
In the last 70 years the use of antibiotics has been crucial in improving countless lives and drastically reducing deaths caused by bacterial infections. The increasing development of antibiotic resistance is posing a serious threat to human health and development, the environment and for animal health. Learn more about ReAct’s work on antibiotic resistance here.
Involved in developing your country's National Action Plan? Here you find support for developing a comprehensive plan.
Doctors, pharmacists, veterinarians and other health care professionals - you have the power to take action! Learn more about how to get started.
Engagement from civil society organizations and communities is needed to tackle antibiotic resistance. Learn more about how to get involved.